Pregnancy-related hypophysitis revisited
European Journal of Endocrinology · 2023
DOI: 10.1093/ejendo/lvad003 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Endocrinology, 2023. Verfasst von Jürgen Honegger und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Eberhard-Karls-University Tübingen, Tübingen, Germany. Hauptthemen laut MEDLINE: Pituitary Diseases, Diabetes Insipidus, Hypophysitis, Autoimmune Hypophysitis. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 114 Literaturangaben.
Abstract (Originalsprache)
Objective
The aim of the study is to assess the distinguishing features of pregnancy-related hypophysitis (PR-Hy) compared to non-pregnancy autoimmune hypophysitis and to evaluate the changing therapeutic approaches and outcomes in PR-Hy over time.
Design
Retrospective analysis of all published cases with PR-Hy and 6 own cases.
Methods
A PubMed search was performed and abstracts screened for publications with information on cases with PR-Hy from which full-text review was performed. Clinical features, diagnostic findings, and outcome in relation to treatment modalities in PR-Hy were assessed.
Results
One hundred and forty-eight cases with PR-Hy were identified. PR-Hy was significantly delimited from non-PR-Hy by the frequent occurrence of the chiasmal syndrome (50% vs 13%, P < .0001), higher rate of intrasellar origin (94% vs 74%, P = .0005), lower rate of pituitary stalk involvement (39% vs 86%, P < .0001), and low rate of diabetes insipidus (12% vs 54%, P < .0001). The role of surgery in PR-Hy decreased over time while noninvasive treatment modalities increased. The recurrence rate after high-dose glucocorticoid therapy (33%) was high and exceeded that of surgery (2%) and conservative management (2%). In contrast to initial reports on PR-Hy, recent literature regarding outcome of mother's and child's health was positive. The frequency of spontaneous preterm delivery was not increased. Recurrent PR-Hy in a subsequent pregnancy was reported in only two females.
Conclusion
PR-Hy has distinct features that delineate the disorder from non-PR-Hy. With increasing experience in diagnosis, availability of adequate replacement therapy, and improved treatment modalities, PR-Hy has lost its threat and the outcome is encouraging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Eberhard-Karls-University Tübingen, Tübingen, Germany.
- Division of Endocrinology, Indiana University, Indianapolis, IN, United States.
ORCID-Profile: Jürgen Honegger, Sabrina Giese, Isabella Nasi-Kordhishti, Diane Mary Donegan
Zitieren
APA
Honegger, J., Giese, S., Nasi-Kordhishti, I., & Donegan, D. M. (2023). Pregnancy-related hypophysitis revisited. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvad003
Vancouver
Honegger J, Giese S, Nasi-Kordhishti I, Donegan DM. Pregnancy-related hypophysitis revisited. European Journal of Endocrinology. 2023. doi:10.1093/ejendo/lvad003
BibTeX
@article{Honegger2023,
author = {Honegger, Jürgen and Giese, Sabrina and Nasi-Kordhishti, Isabella and Donegan, Diane Mary},
title = {Pregnancy-related hypophysitis revisited},
journal = {European Journal of Endocrinology},
year = {2023},
doi = {10.1093/ejendo/lvad003}
}
EUVIMED